Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT

November 14, 2022 updated by: Emily Holmes, Karolinska Institutet

Reducing Intrusive Memories After Trauma Via a Simple Cognitive Intervention During COVID-19 in Hospital Staff: "EKUT-P" (Enkel Kognitiv Uppgift Efter Trauma Under COVID-19 - sjukvårdspersonal) - A Randomized Controlled Trial (RCT)

This research study is designed to investigate the effects of a remotely delivered simple cognitive task (a memory cue followed by playing the computer game "Tetris" with mental rotation instructions) on intrusive memories ("flashbacks") and other symptoms after a traumatic event(s). Hospital staff who experienced a work-related traumatic event(s) during the COVID-19 pandemic will be randomly allocated to either the simple cognitive task intervention or control. Randomization to assigned intervention occurs on Day 1, after completion of baseline measures (note: baseline measures are not used in randomization process). Baseline measures include questionnaires on Day 1 and an intrusive memory diary during the previous week (Week 0). Participants will be followed up at one week and one month, and where possible 3 and 6 months. It is predicted that participants given the simple cognitive task intervention will develop fewer intrusive memories, less severe related clinical symptoms, and will show higher functioning (e.g. at work) than those who are not. This will inform the future development of a simple technique to prevent distressing psychological symptoms after a traumatic event(s). Implementation and training aspects regarding remote recruitment and intervention delivery in a hospital context will also be explored. Participants use e.g. their smartphone for part of the intervention in the study.

Study Overview

Detailed Description

This is a Randomised Controlled Trial informed by prior feasibility and pilot work (ClinicalTrials.gov IDs: NCT03509792, NCT04185155). The primary outcome is the number of intrusive memories of the traumatic event(s) (week 5). The intervention is delivered remotely (e.g. via smartphone) with potential remote support (e.g. by phone) to medical staff in Swedish hospitals.

Study Type

Interventional

Enrollment (Actual)

164

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Huddinge, Sweden, 14157
        • Hospital units across Sweden (e.g. FO Akut, Karolinska University Hospital Huddinge)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged 18 or over
  • Clinical work during the COVID-19 pandemic in hospital and care facilities (e.g. ICU, ambulance, intermediate care, ward)
  • Experienced at least one traumatic event in relation to their clinical work as health care staff during the COVID-19 pandemic
  • This/these event(s) at work meet(s) the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM5) criterion A for Posttraumatic Stress Disorder (PTSD): exposure to actual or threatened death, serious injury, or sexual violence by "Directly experiencing the traumatic event(s)" or "Witnessing, in person, the event(s) as it occurred to others"
  • The traumatic event(s) occured since the start of the COVID-19 pandemic
  • Report memory of the accident
  • Fluent in spoken and written Swedish
  • Alert and orientated
  • Have sufficient physical mobility to use their smartphone
  • Willing and able to provide informed consent and complete study procedures
  • Willing and able to be contacted while the study is ongoing
  • Have access to an internet enabled smartphone
  • Experiences distressing intrusive memories (of a traumatic event in relation to their work as health care staff during the COVID-19 pandemic)
  • Has experienced at least two such intrusive memories of a work-related traumatic event during the week before inclusion/exclusion
  • Able and willing to briefly write down these intrusive memories (without going into any detail)

Exclusion Criteria:

  • Loss of consciousness of > 5 minutes in relation to the traumatic event
  • Current intoxication during the traumatic event or in relation to study inclusion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Simple cognitive task intervention

Session 1: A memory cue followed by playing the computer game "Tetris" (e.g. on own smartphone) with mental rotation instructions.

Options to engage in self-administered/guided booster sessions per intrusive memory.

Session 1: A memory cue followed by playing the computer game "Tetris" (e.g. on own smartphone) with mental rotation instructions.

Options to engage in self-administered/guided booster sessions per intrusive memory.

PLACEBO_COMPARATOR: Attention placebo
Session 1: Digital activity for same amount of time (e.g. listening to podcast on own smartphone).
Session 1: Digital activity for same amount of time (e.g. listening to podcast on own smartphone).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of intrusive memories of traumatic event(s)
Time Frame: Week 5
Number of intrusive memories of traumatic event(s) recorded by participants in a brief diary daily (morning, afternoon, evening and night) for 7 days.
Week 5

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of intrusive memories of traumatic event(s)
Time Frame: Week 0 and Week 1
Number of intrusive memories of traumatic event(s) recorded by participants in a brief diary daily (morning, afternoon, evening and night) for 7 days.
Week 0 and Week 1
Intrusion questionnaire - frequency item
Time Frame: Baseline (Day 1), Week 1 and 5 and 1, 3, and 6 month follow-up
A single item measuring the frequency of intrusive/unwanted memories of the traumatic event(s) in the previous week on a 7-point scale (from "never" to "many times a day", with a follow-up question to specify the number if necessary) that will be used as a convergent measure for medical hospital staff who may face time constraints completing the diary.
Baseline (Day 1), Week 1 and 5 and 1, 3, and 6 month follow-up
Intrusion questionnaire - characteristics
Time Frame: Baseline (Day 1), One week and 1, 3, and 6 month follow-up

5 self-rated items measuring the characteristics of intrusive/unwanted memories in the previous week.

The level of distress, nowness, reliving, disconnectedness and whether different triggers are associated with the intrusive/unwanted memories of the traumatic event(s) are measured on a 101-point scale (from 0 to 100). Higher scores indicate more intrusive/unwanted memories, higher levels of distress/nowness/reliving/disconnectedness and a greater number of different triggers.

Baseline (Day 1), One week and 1, 3, and 6 month follow-up
Impact of Event Scale - Revised (IES-R): Degree of subjective distress of post-trauma intrusion and avoidance symptoms
Time Frame: Baseline (Day 1), One week and 1, 3, and 6 month follow-up
Self-report measure that assesses subjective distress after a traumatic event (with reference to study event[s]) in the last week. Here we include the intrusion subscale (8 items) and the avoidance subscale (8 items). Items are rated on a 5-point scale ranging from 0 ("not at all") to 4 ("extremely"). Subscale scores are calculated for the Intrusion or Avoidance items summed (ranging from 0 to 32 each). Higher scores indicate worse outcome.
Baseline (Day 1), One week and 1, 3, and 6 month follow-up
Posttraumatic Stress Disorder Checklist 5 (PCL-5) short version
Time Frame: Baseline (Day 1), One week and 1, 3, and 6 month follow-up
The PCL-5 short version is an 8-item self-report measure that assesses current symptoms of post-traumatic stress disorder in the last month [Baseline (Day 1), 1, 3, and 6 month follow-up] and in the last week (One week). Items are rated on a 5-point scale ranging from 0 ("not at all") to 4 ("extremely"). The PCL-5 short version yields a total symptom severity score which ranges from 0 to 32. Subscale symptom severity scores for DSM-5 symptom cluster B - intrusion symptoms (items 1-2), cluster C - avoidance (items 3-4), cluster D - negative alterations in cognitions and mood (items 5-6), and cluster E - alterations in arousal and reactivity (items 7-8). Higher scores indicate worse severity.
Baseline (Day 1), One week and 1, 3, and 6 month follow-up
Characteristics of intrusive trauma memories
Time Frame: Baseline (Day 1), Week 1 and week 5
2 self-rated items measuring the level of distress and vividness associated with the intrusions (11 point scales from 0 to 10) rated within the diary at baseline (Day 1), week 1 and week 5. High scores indicate higher level of distress/vividness.
Baseline (Day 1), Week 1 and week 5

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-rated concentration disruption associated with intrusive memories
Time Frame: Baseline (Day 1), Week 1 and Week 5, 1, 3, and 6 months follow-up
Two items measuring the level of concentration disruption associated with the intrusions (11 point scale from 0 to 10) and the duration of disruption (< 1 min, 1-5 min, 5-10 min, 10-30 min, 30-60 min, > 60 min). High scores indicate higher level of concentration disruption and longer duration of disruption.
Baseline (Day 1), Week 1 and Week 5, 1, 3, and 6 months follow-up
Concentration and memory difficulties
Time Frame: 6 month follow-up
Eleven items assess the extent of concentration and memory difficulties during the previous four weeks, using a 5-point scale (1 'Virtually every day' to 5 'Never'). Total scores range from 11 to 55; higher scores indicate less concentration and memory difficulties.
6 month follow-up
Self-rated functioning and social support ratings
Time Frame: Baseline (Day 1), One week, 1, 3, and 6 month follow up
3 bespoke items including a question on impact on work-related functioning, and one on daily functioning in other areas associated with the intrusions and a question on perceived social support after the traumatic event. All items are rated on an 11-point scale (from 0 "none"; 5 "some"; 10 "extreme/much"). Higher scores indicate higher level of functional impairment/perceived social support.
Baseline (Day 1), One week, 1, 3, and 6 month follow up
Appraisals of intrusive memories
Time Frame: Baseline (Day 1), One week, 1, 3, and 6 month follow-up
6 self-report items (11-point scale from 0 to 100) measuring appraisals of intrusions on two subscales: psychological problems (items 1-3) and negative self-evaluations (items 4-6). Items for each subscale will be summed. Possible subscale scores range from 0 - 300, with higher values indicative of worse appraisals.
Baseline (Day 1), One week, 1, 3, and 6 month follow-up
Self-rated sleep ratings
Time Frame: Baseline (Day 1), one week and 1, 3, and 6 month follow-up
Two self rated items: Item 1 measures the extent of being troubled by poor sleep (with reference to study event) on a 5 point scale (from not at all to very much), and item 2 measures the number of nights in the week with sleep problems on a 5 point scale (from 0-1 to 5-7 nights). Each 5-point scale is reverse scored (4 - 0) then summed. Possible total scores range from 0 - 8, with higher values indicative of better sleep.
Baseline (Day 1), one week and 1, 3, and 6 month follow-up
Self Rated Health (SRH) rating
Time Frame: Baseline (Day 1), one week, and 1, 3, and 6 month follow-up
A single item measuring perceived health status on a seven-point scale (from very good to very bad). The scale is reverse scored. High scores indicate good outcomes.
Baseline (Day 1), one week, and 1, 3, and 6 month follow-up
Questions related to work situation
Time Frame: Baseline (Day 1), One week, 1, 3, and 6 month follow-up
3 free text response field questions (e.g. which type of health care do you work with right now?) at Day 1 and two free text response field questions on whether the work situation changed and if yes, how, at one week, 1, 3, and 6 month follow-up.
Baseline (Day 1), One week, 1, 3, and 6 month follow-up
Sick leave
Time Frame: Baseline (Day 1), One week, 1, 3, and 6 month follow-up
2 bespoke items measuring the total number and the number of full work days on sick leave because of reason for seeking health care. Higher numbers indicate more sick leave.
Baseline (Day 1), One week, 1, 3, and 6 month follow-up
Stress and Energy Questionnaire (SEQ) - Stress subscale
Time Frame: Baseline (Day 1), One week, 1, 3, and 6 month follow-up
3 items measuring the frequency of feeling stressed, pressured, tensed at work during the previous week on a 5-point scale (from "never" to "several times per day"). Item scores are summed. Higher scores indicate higher levels of stress. Further, a single item measuring difficulties to let go of work-related thoughts during leisure time (from "very rarely or never" to "very often or always") and a single question about whether the above mentioned difficulties are because of intrusive memories with a yes/no response.
Baseline (Day 1), One week, 1, 3, and 6 month follow-up
Scale of Work Engagement and Burnout (SWEBO) - Burnout subscale
Time Frame: Baseline (Day 1) and 6 month follow-up
9 self-report items (4-point scale from 1 "not at all" to 4 "all the time") measuring symptoms of burnout on three subscales: Exhaustion (items 1-3), disengagement (items 4-6) and inattentiveness (items 7-9). Subscale scores will be the mean of all items per subscale, the total burnout score will be the mean of all items (ranging from 1-4) with higher scores indicative of higher levels of exhaustion/disengagement/inattentiveness/burnout.
Baseline (Day 1) and 6 month follow-up
Moral stress at work
Time Frame: Baseline (Day 1), One week, 1, 3, and 6 month follow-up
5 self-report items measuring moral stress at work on a 4-point scale ranging from 1 ("Strongly agree") to 4 ("Strongly disagree"). All items are summed. Potential scores range from 5-20, with higher scores indicative of lower levels of moral stress.
Baseline (Day 1), One week, 1, 3, and 6 month follow-up
Adverse events
Time Frame: One week and 1, 3, and 6 month follow-up
A free text response field measuring the occurrence of any health problems since the last contact.
One week and 1, 3, and 6 month follow-up
Future self questionnaire - shortened version
Time Frame: 3 month follow-up
A free text response field asking to imagine a future self identity. Then a free text response field to describe a mental image of this identity, 2 items measuring vividness (from 1 "not vivid at all" to 10 "very vivid") and positivity (from 1 "very negative" to 10 "very positive") of that image on a 10-point scale and 1 item measuring the perspective of viewing that mental image ("through own eyes" or "as if seeing oneself") before and after the traumatic event(s). Higher scores on rating scales indicate higher levels of vividness/positivity.
3 month follow-up
Time perspective questionnaire
Time Frame: Baseline (Day 1), One week, 1, 3, and 6 month follow-up
8 self-report items (5-point scale from 1 to 5) measuring time perspective on three subscales: past perspective (items 3, 5, 7), present perspective (items 1, 8) and future perspective (items 2, 4, 6). Item scores for each subscale will be summed. Higher values indicate higher levels of past/present/future time perspective.
Baseline (Day 1), One week, 1, 3, and 6 month follow-up
Coping mechanisms
Time Frame: Baseline (Day 1)
2 free text response field questions (e.g. Are there any specific factors you think have made it easier for you to handle the COVID-19 situation and its consequences?) at Day 1.
Baseline (Day 1)
WHODAS 2.0
Time Frame: 6 month follow-up
12 self-rated items assessing functioning in six life domains: 1) cognition, 2) mobility, 3) personal care 4) relations, 5) daily activities and 6) participation in society. Each item is rated on a 5-point scale, from 1 ("none") to 5 ("extreme or cannot do") and summed; a higher sum score indicates worse functioning. An additional three questions are asked at the end regarding the frequency and impact of these items.
6 month follow-up
Credibility/expectancy questionnaire
Time Frame: Day 1
5 item questionnaire (11-point scale from 0 to 10) that rates to what degree the participant finds the intervention credible. High scores indicate greater credibility.
Day 1
Subjective Units of Distress (SUDS)
Time Frame: Day 1
A bespoke manipulation check item measuring self-rated distress during the intervention/control procedure (11-point scale from 0 to 10) at 3 times during the intervention process. Higher scores indicate higher level of distress.
Day 1
Feedback questionnaire about participation
Time Frame: 1 month follow-up
8 bespoke items including questions about study participation e.g. how acceptable was it to do the task? Rated on 11-point scale from 0 (not at all) to 10 (extremely), higher scores indicate higher acceptability; and questions about what has happened since the study with a yes/no response e.g. have you had any psychological or medical treatment since you did the task; and items with a free text response field e.g. do you have any other comments.
1 month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Emily Holmes, Prof, Karolinska Institutet/Uppsala University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 30, 2020

Primary Completion (ACTUAL)

June 16, 2022

Study Completion (ACTUAL)

October 31, 2022

Study Registration Dates

First Submitted

July 6, 2020

First Submitted That Met QC Criteria

July 6, 2020

First Posted (ACTUAL)

July 7, 2020

Study Record Updates

Last Update Posted (ACTUAL)

November 15, 2022

Last Update Submitted That Met QC Criteria

November 14, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post Traumatic Stress Disorder

Clinical Trials on Simple cognitive task intervention

3
Subscribe